Holleran G - Search Results

1

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.

Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. Holleran G, et al. Int J Mol Sci. 2017 Sep 21;18(10):2020. doi: 10.3390/ijms18102020. Int J Mol Sci. 2017. PMID: 28934123 Free PMC article. Review.

2

Gut microbiota and inflammatory bowel disease: so far so gut!

Holleran G, Lopetuso LR, Ianiro G, Pecere S, Pizzoferrato M, Petito V, Graziani C, McNAMARA D, Gasbarrini A, Scaldaferri F. Holleran G, et al. Minerva Gastroenterol Dietol. 2017 Dec;63(4):373-384. doi: 10.23736/S1121-421X.17.02386-8. Epub 2017 Mar 14. Minerva Gastroenterol Dietol. 2017. PMID: 28293937 Review.

3

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

Scaldaferri F, D'Ambrosio D, Holleran G, Poscia A, Petito V, Lopetuso L, Graziani C, Laterza L, Pistone MT, Pecere S, Currò D, Gaetani E, Armuzzi A, Papa A, Cammarota G, Gasbarrini A. Scaldaferri F, et al. Among authors: holleran g. PLoS One. 2017 Oct 26;12(10):e0186575. doi: 10.1371/journal.pone.0186575. eCollection 2017. PLoS One. 2017. PMID: 29073159 Free PMC article.

4

The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.

Hussey M, Holleran G, Smith S, Sherlock M, McNamara D. Hussey M, et al. Among authors: holleran g. Dig Dis Sci. 2017 Dec;62(12):3385-3390. doi: 10.1007/s10620-017-4753-1. Epub 2017 Sep 20. Dig Dis Sci. 2017. PMID: 28932959

5

Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.

Holleran G, Scaldaferri F, Ianiro G, Lopetuso L, Mc Namara D, Mele MC, Gasbarrini A, Cammarota G. Holleran G, et al. Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Drugs Today (Barc). 2018. PMID: 29637938 Review.

6

Small bowel Crohn's disease: an emerging disease phenotype?

Hall B, Holleran G, McNamara D. Hall B, et al. Among authors: holleran g. Dig Dis. 2015;33(1):42-51. doi: 10.1159/000366047. Epub 2014 Dec 17. Dig Dis. 2015. PMID: 25531496 Review.

7

Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD).

Pecere S, Holleran G, Ainora ME, Garcovich M, Scaldaferri F, Gasbarrini A, Zocco MA. Pecere S, et al. Among authors: holleran g. Dig Liver Dis. 2018 Aug;50(8):761-767. doi: 10.1016/j.dld.2018.03.023. Epub 2018 Apr 3. Dig Liver Dis. 2018. PMID: 29705029 Review.

8

An overview of angiodysplasia: management and patient prospects.

Holleran G, McNamara D. Holleran G, et al. Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):863-872. doi: 10.1080/17474124.2018.1503532. Epub 2018 Aug 3. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30028221 Review.

9

Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials.

Holleran G, Scaldaferri F, Gasbarrini A, Currò D. Holleran G, et al. Phytother Res. 2020 Jan;34(1):77-93. doi: 10.1002/ptr.6517. Epub 2019 Nov 7. Phytother Res. 2020. PMID: 31701598 Review.

10

Current applications and potential future role of wireless capsule technology in Crohn's disease.

Hall B, Holleran G, McNamara D. Hall B, et al. Among authors: holleran g. Scand J Gastroenterol. 2014 Nov;49(11):1275-84. doi: 10.3109/00365521.2014.962606. Epub 2014 Sep 26. Scand J Gastroenterol. 2014. PMID: 25260016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters